138 related articles for article (PubMed ID: 28672948)
21. Resveratrol reduces prostaglandin E1-stimulated osteoprotegerin synthesis in osteoblasts: suppression of stress-activated protein kinase/c-Jun N-terminal kinase.
Yamamoto N; Otsuka T; Kuroyanagi G; Kondo A; Kainuma S; Nakakami A; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Prostaglandins Other Lipid Mediat; 2015; 116-117():57-63. PubMed ID: 25677506
[TBL] [Abstract][Full Text] [Related]
22. (-)-Epigallocatechin gallate attenuates the induction of HSP27 stimulated by sphingosine 1-phosphate via suppression of phosphatidylinositol 3-kinase/Akt pathway in osteoblasts.
Natsume H; Adachi S; Takai S; Tokuda H; Matsushima-Nishiwaki R; Minamitani C; Yamauchi J; Kato K; Mizutani J; Kozawa O; Otsuka T
Int J Mol Med; 2009 Aug; 24(2):197-203. PubMed ID: 19578793
[TBL] [Abstract][Full Text] [Related]
23. (-)-Epigallocatechin gallate inhibits basic fibroblast growth factor-stimulated interleukin-6 synthesis in osteoblasts.
Tokuda H; Takai S; Hanai Y; Matsushima-Nishiwaki R; Yamauchi J; Harada A; Hosoi T; Ohta T; Kozawa O
Horm Metab Res; 2008 Oct; 40(10):674-8. PubMed ID: 18500674
[TBL] [Abstract][Full Text] [Related]
24. Green tea (-)-epigallocatechin gallate induced growth inhibition of human placental choriocarcinoma cells.
Shih LJ; Lin YR; Lin CK; Liu HS; Kao YH
Placenta; 2016 May; 41():1-9. PubMed ID: 27208402
[TBL] [Abstract][Full Text] [Related]
25. Suppression by HSP90 inhibitors of BMP‑4‑stimulated osteoprotegerin synthesis in osteoblasts: Attenuation of p70 S6 kinase.
Kawabata T; Otsuka T; Fujita K; Kainuma S; Yamamoto N; Kuroyanagi G; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Mol Med Rep; 2017 Dec; 16(6):8507-8512. PubMed ID: 28983611
[TBL] [Abstract][Full Text] [Related]
26. (-)-epigallocatechin gallate inhibits prostaglandin D2-stimulated HSP27 induction via suppression of the p44/p42 MAP kinase pathway in osteoblasts.
Yamauchi J; Takai S; Matsushima-Nishiwaki R; Hanai Y; Doi T; Kato H; Ogura S; Kato K; Tokuda H; Kozawa O
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):173-9. PubMed ID: 17949962
[TBL] [Abstract][Full Text] [Related]
27. Sphingomyelinase amplifies BMP-4-induced osteocalcin synthesis in osteoblasts: role of ceramide.
Kozawa O; Hatakeyama D; Tokuda H; Oiso Y; Matsuno H; Uematsu T
Cell Signal; 2002 Dec; 14(12):999-1004. PubMed ID: 12359305
[TBL] [Abstract][Full Text] [Related]
28. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.
Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT
J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655
[TBL] [Abstract][Full Text] [Related]
29. Resveratrol amplifies BMP-4-stimulated osteoprotegerin synthesis via p38 MAP kinase in osteoblasts.
Kuroyanagi G; Tokuda H; Yamamoto N; Matsushima-Nishiwaki R; Mizutani J; Kozawa O; Otsuka T
Mol Med Rep; 2015 Sep; 12(3):3849-3854. PubMed ID: 26044505
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of adenosine monophosphate-activated protein kinase suppresses bone morphogenetic protein-2-induced mineralization of osteoblasts via Smad-independent mechanisms.
Takeno A; Kanazawa I; Notsu M; Tanaka KI; Sugimoto T
Endocr J; 2018 Mar; 65(3):291-298. PubMed ID: 29249772
[TBL] [Abstract][Full Text] [Related]
31. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
[TBL] [Abstract][Full Text] [Related]
32. Suppression by resveratrol of prostaglandin D2-stimulated osteoprotegerin synthesis in osteoblasts.
Kuroyanagi G; Mizutani J; Kondo A; Yamamoto N; Matsushima-Nishiwaki R; Otsuka T; Kozawa O; Tokuda H
Prostaglandins Leukot Essent Fatty Acids; 2014 Sep; 91(3):73-80. PubMed ID: 24813642
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of PI3K/p70 S6K and p38 MAPK cascades increases osteoblastic differentiation induced by BMP-2.
Viñals F; López-Rovira T; Rosa JL; Ventura F
FEBS Lett; 2002 Jan; 510(1-2):99-104. PubMed ID: 11755539
[TBL] [Abstract][Full Text] [Related]
34. Tramadol enhances PGF
Kim W; Tanabe K; Kuroyanagi G; Matsushima-Nishiwaki R; Fujita K; Kawabata T; Sakai G; Tachi J; Hioki T; Nakashima D; Yamaguchi S; Otsuka T; Tokuda H; Kozawa O; Iida H
Heliyon; 2020 Aug; 6(8):e04779. PubMed ID: 32904295
[TBL] [Abstract][Full Text] [Related]
35. Possible involvement of AMP-activated protein kinase in PGE
Kainuma S; Otsuka T; Kuroyanagi G; Yamamoto N; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Exp Ther Med; 2016 May; 11(5):2042-2048. PubMed ID: 27168848
[TBL] [Abstract][Full Text] [Related]
36. Green tea polyphenol (-)-epigallocatechin gallate suppressed the differentiation of murine osteoblastic MC3T3-E1 cells.
Kamon M; Zhao R; Sakamoto K
Cell Biol Int; 2009 Dec; 34(1):109-16. PubMed ID: 19947947
[TBL] [Abstract][Full Text] [Related]
37. Regulation by resveratrol of prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts.
Yamamoto N; Tokuda H; Kuroyanagi G; Mizutani J; Matsushima-Nishiwaki R; Kondo A; Kozawa O; Otsuka T
Int J Mol Med; 2014 Nov; 34(5):1439-45. PubMed ID: 25234201
[TBL] [Abstract][Full Text] [Related]
38. Mimosine suppresses the PGF2α-induced synthesis of osteoprotegerin but not interleukin-6 in osteoblasts.
Kuroyanagi G; Otsuka T; Yamamoto N; Kainuma S; Ohguchi R; Fujita K; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Int J Mol Med; 2016 Feb; 37(2):533-41. PubMed ID: 26744072
[TBL] [Abstract][Full Text] [Related]
39. Chlorogenic acid combined with epigallocatechin-3-gallate mitigates D-galactose-induced gut aging in mice.
Wei R; Su Z; Mackenzie GG
Food Funct; 2023 Mar; 14(6):2684-2697. PubMed ID: 36752162
[TBL] [Abstract][Full Text] [Related]
40. PGD2 stimulates osteoprotegerin synthesis via AMP-activated protein kinase in osteoblasts: Regulation of ERK and SAPK/JNK.
Kainuma S; Tokuda H; Kuroyanagi G; Yamamoto N; Ohguchi R; Fujita K; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
Prostaglandins Leukot Essent Fatty Acids; 2015 Oct; 101():23-9. PubMed ID: 26365271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
